CVC  McKesson Ventures

http://ventures.mckesson.com/





     Office Locations:

One Post Street
San Francisco, CA 94104

 

Stages:

  • Early
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    McKesson Ventures is the venture capital arm of McKesson Corporation, currently ranked 11th on the FORTUNE 500 list. McKesson is a healthcare services and information technology company dedicated to making the business of healthcare run better. Since 2008, McKesson Ventures has invested $13.7 billion in acquisitions in health care technology and services. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the health care ecosystem. The firm seeks companies in emerging growth areas at the center of these changes, including: consumerism, alternative care delivery models, employer enablement, and data supply chain.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Aaron Flink Investment Manager
    David Schulte Managing Director
    Jennifer Carter Vice President
    Tom Rodgers Senior Vice President and Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/06/2017


      Truveris


      NY


      $25,000,000


      Series D


      03/02/2017


      Grail


      CA


      $900,000,000


      Series B


     

    Portfolio companies include:


      Accolade
        web link


      Augmedix
        web link


      Carena
        web link


      eVariant
        web link


      Grail
        web link


      Kyruus
        web link


      PipelineRx
        web link


      RetraceHealth
        web link


      Rock Health
        web link


      Shyft Analytics
        web link


      Truveris
        web link


     

    Recent News: